Marvin 04231312222D 17 16 0 0 0 0 999 V2000 13.1479 -7.9558 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 12.4333 -6.7185 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 13.1479 -10.4308 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 13.8623 -9.1935 0.0000 O 0 5 0 0 0 0 0 0 0 0 0 0 11.0045 -8.3683 0.0000 N 0 3 0 0 0 0 0 0 0 0 0 0 12.4333 -8.3683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 11.7191 -7.9558 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 14.5768 -7.1308 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 13.8623 -6.7185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 12.4333 -9.1935 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10.2901 -8.7810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 15.2911 -6.7185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 13.1479 -7.1308 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 13.1479 -9.6060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10.2901 -7.9558 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 11.0045 -9.1933 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 13.8622 -5.8935 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 6 1 0 0 0 0 1 13 1 0 0 0 0 2 13 2 0 0 0 0 3 14 2 0 0 0 0 4 14 1 0 0 0 0 5 7 1 0 0 0 0 5 11 1 0 0 0 0 6 7 1 0 0 0 0 6 10 1 0 0 0 0 8 9 2 0 0 0 0 8 12 1 0 0 0 0 9 13 1 0 0 0 0 10 14 1 0 0 0 0 5 15 1 0 0 0 0 5 16 1 0 0 0 0 9 17 1 0 0 0 0 M CHG 2 4 -1 5 1 M END > CHEBI:71179 > O-tiglylcarnitine > An O-acylcarnitine compound having trans-2-methyl-2-butenoyl (tiglyl) as the acyl substituent. > 3 > tiglylcarnitine; 3-{[(2E)-2-methylbut-2-enoyl]oxy}-4-(trimethylammonio)butanoate > 3-{[(2E)-2-methylbut-2-enoyl]oxy}-4-(trimethylazaniumyl)butanoate > C12H21NO4 > 243.29940 > 243.14706 > 0 > C\C=C(/C)C(=O)OC(CC([O-])=O)C[N+](C)(C)C > InChI=1S/C12H21NO4/c1-6-9(2)12(16)17-10(7-11(14)15)8-13(3,4)5/h6,10H,7-8H2,1-5H3/b9-6+ > WURBQCVBQNMUQT-RMKNXTFCSA-N > 64191-86-2 > 14518824; 22770225; 23315938 $$$$